🚀 Early Adopter Price: $39/mo for life --d --h --m --s Claim Your Price →
Coming Soon
Expected availability announced soon

This course is in active development. Preview the scope below and create a free account to be notified the moment it goes live.

Notify me
Continuing Education Coming Soon

CE Immunization Administration Pharmacist

The course teaches pharmacists the latest CDC immunization schedules, proper vaccine storage, documentation, safety monitoring, and administration techniques, ensuring compliant, effective patient immunizations and emergency response protocols.

Who Should Take This

Pharmacists who are credentialed to administer vaccines and seek to maintain up‑to‑date knowledge of CDC guidelines should enroll. Ideal participants have at least one year of immunization experience, desire to refine documentation and cold‑chain practices, and need to meet continuing‑education requirements for state licensure.

What's Included in AccelaStudy® AI

Adaptive Knowledge Graph
Practice Questions
Lesson Modules
Console Simulator Labs
Exam Tips & Strategy
20 Activity Formats

Course Outline

63 learning goals
1 CDC Immunization Schedules
3 topics

Adult immunization schedule

  • Identify the vaccines recommended on the current CDC adult immunization schedule including influenza, Tdap, shingles, pneumococcal, and COVID-19 vaccines.
  • Explain age-based and risk-based recommendations for adult vaccines including the two-dose shingles series, pneumococcal vaccine sequencing, and hepatitis B universal recommendation.
  • Analyze a patient's immunization history and medical conditions to determine which adult vaccines are indicated, contraindicated, or require special timing considerations.

Pediatric immunization schedule

  • Identify the vaccines on the current CDC childhood and adolescent immunization schedule from birth through 18 years including DTaP, IPV, MMR, varicella, and HPV series.
  • Explain minimum age and minimum interval requirements for childhood vaccines and the catch-up schedule for children who have fallen behind.
  • Analyze a child's vaccination record with missed doses to create an individualized catch-up schedule using CDC minimum interval guidelines.

Special populations

  • Identify vaccine contraindications and precautions for immunocompromised patients including those on biologics, chemotherapy, or organ transplant immunosuppression.
  • Describe vaccine recommendations for pregnant patients including which vaccines are recommended, which are contraindicated, and the timing of Tdap during each pregnancy.
  • Evaluate immunization scenarios for healthcare workers to determine occupational vaccine requirements including hepatitis B titer verification, annual influenza, and MMR immunity evidence.
2 Vaccine Storage and Cold Chain Management
2 topics

Storage requirements

  • Identify proper temperature ranges for refrigerated vaccines (2-8°C) and frozen vaccines (-50°C to -15°C) and the storage unit specifications recommended by CDC.
  • Explain the requirements for continuous digital temperature monitoring including data logger specifications, calibration, twice-daily documentation, and alarm threshold settings.
  • Describe proper vaccine placement within storage units including avoiding doors, walls, and floors, using water bottles for thermal stability, and never storing food or beverages.

Temperature excursions and emergency protocols

  • Identify the steps to take during a temperature excursion event including isolating affected vaccines, documenting the excursion, and contacting the manufacturer for viability guidance.
  • Analyze temperature monitoring data to determine whether vaccines remain viable after a storage excursion using manufacturer stability data and CDC guidance.
  • Explain emergency vaccine storage procedures during power outages including backup power requirements, transport protocols, and alternative storage site arrangements.
  • Design a comprehensive vaccine storage and handling standard operating procedure for a pharmacy including receiving, unpacking, storing, monitoring, rotating, and disposing of expired vaccines.
  • Evaluate the financial and public health impact of vaccine wastage due to cold chain failures and recommend quality improvement measures to minimize losses.
3 Vaccine Information Statements and Documentation
2 topics

VIS requirements and legal obligations

  • Identify the legal requirement under the National Childhood Vaccine Injury Act to provide a current Vaccine Information Statement prior to each vaccination.
  • Explain the documentation requirements for vaccine administration including vaccine name, manufacturer, lot number, expiration date, injection site, route, VIS edition date, and administrator information.
  • Describe the National Vaccine Injury Compensation Program including covered vaccines, filing deadlines, the Vaccine Injury Table, and the relationship to civil litigation.

Immunization information systems

  • Identify state immunization information systems and their role in consolidating vaccination records, facilitating clinical decision support, and supporting population-level coverage assessment.
  • Analyze the pharmacist's responsibilities for reporting administered vaccines to state immunization registries including data elements, reporting timelines, and bidirectional data exchange.
  • Design a vaccine documentation workflow that integrates VIS distribution, informed consent, administration records, state registry reporting, and insurance billing into pharmacy operations.
4 VAERS and Vaccine Safety Monitoring
2 topics

Reporting requirements and systems

  • Identify the Vaccine Adverse Event Reporting System and distinguish between mandatory reporting events on the VAERS Table of Reportable Events and voluntary adverse event reports.
  • Explain the process for submitting a VAERS report including required data elements, online reporting portal, timeline expectations, and the role of follow-up information requests.
  • Describe the complementary vaccine safety surveillance systems including the Vaccine Safety Datalink, Clinical Immunization Safety Assessment project, and post-licensure safety studies.

VAERS data interpretation

  • Analyze the limitations of VAERS data including reporting bias, inability to determine causation, denominator uncertainty, and the difference between temporal association and causation.
  • Evaluate vaccine safety concerns raised by patients using evidence-based resources to provide accurate risk-benefit communication and address vaccine hesitancy.
5 Pharmacist Authority and Administration Technique
2 topics

Legal authority and protocols

  • Identify the legal mechanisms authorizing pharmacist vaccine administration including state pharmacy practice acts, collaborative practice agreements, standing orders, and PREP Act declarations.
  • Explain pharmacist training and certification requirements for immunization administration including APhA certificate programs, BLS certification, and state-specific additional requirements.
  • Describe the provisions and limitations of the PREP Act as applied to pharmacist-administered vaccinations including covered countermeasures, liability protections, and age restrictions.

Administration technique

  • Identify proper injection technique for intramuscular, subcutaneous, and intradermal vaccine administration including needle gauge, length, angle of insertion, and anatomic site selection.
  • Explain vaccine reconstitution procedures including diluent verification, mixing technique, use-time limitations after reconstitution, and documentation of reconstitution time.
  • Analyze vaccine administration errors including wrong route, wrong dose, and wrong site to determine whether revaccination is necessary using CDC guidance on administration errors.
  • Evaluate the feasibility and best practices for simultaneous administration of multiple vaccines at the same visit including site spacing, contraindications to co-administration, and patient counseling.
6 Travel Vaccines and International Immunization
2 topics

Travel vaccine recommendations

  • Identify travel vaccines commonly recommended by the CDC including yellow fever, typhoid, hepatitis A and B, Japanese encephalitis, rabies, meningococcal, and cholera vaccines.
  • Explain the yellow fever vaccine requirements for international travel including International Certificate of Vaccination, designated yellow fever vaccination centers, and country-specific entry requirements.
  • Describe malaria chemoprophylaxis options including atovaquone-proguanil, doxycycline, mefloquine, and chloroquine with appropriate regimen selection based on destination resistance patterns.

Travel health consultation

  • Analyze an itinerary-based travel health assessment to determine required and recommended immunizations based on destination, duration, activities, and traveler health status.
  • Evaluate the timing constraints for travel vaccines to ensure adequate immune response before departure and determine accelerated schedules when available.
  • Identify non-vaccine travel health measures including insect bite prevention, food and water precautions, travelers' diarrhea self-treatment, and altitude sickness prevention.
  • Design a pharmacist-led travel health consultation service including pre-travel assessment forms, vaccine protocols, medication dispensing, and patient education materials.
7 Anaphylaxis Recognition and Emergency Management
2 topics

Recognition and response

  • Identify the signs and symptoms of anaphylaxis including urticaria, angioedema, bronchospasm, hypotension, and gastrointestinal symptoms and distinguish anaphylaxis from vasovagal syncope.
  • Explain the mechanism of anaphylaxis including IgE-mediated and non-IgE-mediated pathways and the rationale for immediate epinephrine administration as first-line treatment.
  • Describe the correct technique for intramuscular epinephrine administration during anaphylaxis including dose, injection site, positioning of the patient, and criteria for repeat dosing.

Emergency preparedness

  • Analyze post-vaccination observation periods and risk factors that warrant extended monitoring including history of allergic reactions, multiple allergen sensitivities, and mast cell disorders.
  • Evaluate the required contents of a pharmacy anaphylaxis emergency kit and the frequency of supply checks, expiration monitoring, and staff competency drills.
  • Design an anaphylaxis emergency response protocol for a community pharmacy immunization program including staff roles, epinephrine administration, EMS activation, documentation, and post-event follow-up.
8 Vaccine Communication and Patient Education
2 topics

Patient counseling strategies

  • Identify common vaccine misconceptions and misinformation themes including autism claims, ingredient fears, natural immunity superiority, and overloading the immune system.
  • Explain evidence-based motivational interviewing techniques for addressing vaccine hesitancy including active listening, empathy, asking permission, and providing tailored information.
  • Describe strategies for communicating vaccine risks and benefits to patients with limited health literacy including plain language, visual aids, and the teach-back method.

Population-level immunization

  • Analyze barriers to vaccine uptake in underserved communities including access, cost, cultural factors, language barriers, and historical medical mistrust.
  • Evaluate pharmacy-based immunization outreach programs for effectiveness in improving community vaccination rates through mobile clinics, employer partnerships, and walk-in accessibility.
  • Identify public health reporting obligations for vaccine-preventable disease cases and the pharmacist's role in disease surveillance and outbreak response coordination.
  • Design a community pharmacy immunization marketing and outreach plan that addresses local population demographics, seasonal timing, insurance acceptance, and health equity considerations.
9 Vaccine Types and Mechanisms of Action
2 topics

Vaccine platforms and immune response

  • Identify the major vaccine types including live-attenuated, inactivated, subunit, conjugate, toxoid, mRNA, and viral vector platforms and name examples of each.
  • Explain how mRNA vaccines generate an immune response including antigen presentation, B-cell activation, T-cell response, and the rationale for lipid nanoparticle delivery.
  • Describe the differences in immune response between live-attenuated and inactivated vaccines including duration of immunity, booster requirements, and shedding considerations.
  • Analyze the contraindications for live vaccines in immunocompromised patients and determine which non-live alternatives are available for each vaccine-preventable disease.

Vaccine adjuvants and formulations

  • Identify common vaccine adjuvants including aluminum salts, AS01B, AS04, MF59, and CpG 1018 and explain their purpose in enhancing immune response.
  • Explain the role of vaccine preservatives, stabilizers, and residual manufacturing components and address patient concerns about specific ingredients including thimerosal and formaldehyde.
  • Evaluate the clinical significance of egg protein content in influenza and yellow fever vaccines for patients with egg allergies using current ACIP guidance.
  • Design a screening protocol for vaccine allergies and contraindications that pharmacists can use during pre-vaccination assessment including ingredient-specific allergy evaluation.

Scope

Included Topics

  • CDC immunization schedules for adults and children including routine recommendations, catch-up schedules, and special population considerations for immunocompromised, pregnant, and healthcare worker groups.
  • Vaccine storage and cold chain management including temperature monitoring, storage unit requirements, emergency protocols for temperature excursions, and CDC Vaccine Storage and Handling Toolkit guidance.
  • Vaccine Information Statement requirements including timing of distribution, documentation, available languages, and the legal obligation under the National Childhood Vaccine Injury Act.
  • VAERS reporting including mandatory reporting requirements for healthcare providers, voluntary reports, data interpretation limitations, and the relationship between VAERS and the Vaccine Safety Datalink.
  • Pharmacist authority to immunize including state-specific protocols, PREP Act authority, collaborative practice agreements, standing orders, and age-group restrictions by jurisdiction.
  • Travel vaccine recommendations including yellow fever, typhoid, hepatitis A, Japanese encephalitis, rabies pre-exposure prophylaxis, and malaria chemoprophylaxis consultation.
  • Anaphylaxis recognition and emergency management in the pharmacy including epinephrine administration, patient assessment, emergency medical services activation, and post-event documentation.

Not Covered

  • Vaccine development, manufacturing processes, or regulatory approval pathways beyond pharmacist-level understanding of vaccine types and mechanisms.
  • Detailed immunology beyond the level needed to understand vaccine-induced immunity, contraindications, and adverse reactions.
  • Public health policy debates about vaccine mandates, philosophical exemptions, or anti-vaccine movements beyond addressing patient hesitancy with evidence-based communication.
  • Veterinary vaccines or non-human immunization programs.

CE Immunization Administration Pharmacist is coming soon

Adaptive learning that maps your knowledge and closes your gaps.

Create Free Account to Be Notified